Sarcopenia: European consensus on definition and diagnosis
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 80 of the 80 references it cites were found in a registry or an index.
Abstract
The European Working Group on Sarcopenia in Older People (EWGSOP) developed a practical clinical definition and consensus diagnostic criteria for age-related sarcopenia. EWGSOP included representatives from four participant organisations, i.e. the European Geriatric Medicine Society, the European Society for Clinical Nutrition and Metabolism, the International Association of Gerontology and Geriatrics—European Region and the International Association of Nutrition and Aging. These organisations endorsed the findings in the final document. The group met and addressed the following questions, using the medical literature to build evidence-based answers: (i) What is sarcopenia? (ii) What parameters define sarcopenia? (iii) What variables reflect these parameters, and what measurement tools and cut-off points can be used? (iv) How does sarcopenia relate to cachexia, frailty and sarcopenic obesity? For the diagnosis of sarcopenia, EWGSOP recommends using the presence of both low muscle mass + low muscle function (strength or performance). EWGSOP variously applies these characteristics to further define conceptual stages as ‘presarcopenia’, ‘sarcopenia’ and ‘severe sarcopenia’. EWGSOP reviewed a wide range of tools that can be used to measure the specific variables of muscle mass, muscle strength and physical performance. Our paper summarises currently available data defining sarcopenia cut-off points by age and gender; suggests an algorithm for sarcopenia case finding in older individuals based on measurements of gait speed, grip strength and muscle mass; and presents a list of suggested primary and secondary outcome domains for research. Once an operational definition of sarcopenia is adopted and included in the mainstream of comprehensive geriatric assessment, the next steps are to define the natural course of sarcopenia and to develop and define effective treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The European Working Group for the Study of Sarcopenia (EWGSOP)156 identified sarcopenia cut-off points and tools for its measurement. They recognized the lack of diagnostic criteria for sarcopenia but integrated low muscle mass and function (strength or performance) in their terminology, believing that the relationship between these two measures is not linear nor bidirectional73,156,181.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [156]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This algorithm was meant for clinical application using gait speed (<0.8 m/s) before muscle mass or strength measurement.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [156]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Also, the cut-off points for the Asian populations [9] are lower than for the non-Asian individuals [7] in both genders, with young people of the same ethnic group as reference.”
From Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies (2017) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to the amount of skeletal muscle, other conditions also affect functional outcomes: muscle quality, total body fat, neurologic function, cardiovascular and pulmonary function, and other comorbid conditions.16,208”
From Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In older people, loss of muscle strength is associated with reduced functional capacity and increased health care costs.16”
From Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) · cites this paper as [16]
Experimental — accuracy not yet measured
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907 · cited 3×
“Men: Based on quartiles of study group (n = 5,317) [27]”
BackgroundGuralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792 · cited 1×
“The SPPB evaluates balance, gait, strength and endurance by examining an individual’s ability to stand with the feet together in side-by-side, semi-tandem and tandem positions, time to walk 8 ft and time to rise from a chair and return to the seated position five times [58].”
BackgroundEpidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 13×
“The re- searchers concluded that BIA was a clinically relevant measure muscle function, which would be particularly useful for patients unable or unwilling to perform grip strength tests.”
BackgroundMethodInfluentialPrado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238 · cited 1×
“In conditions such as malignancy, rheumatoid arthritis and ageing, lean bodymass is lost while fat mass may be preserved or even increased [28].”
BackgroundJanssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139 · cited 2×
“[67] also used standard deviations to define sarcopenia, measured in terms of skeletal muscle index (SMI), where SMI = (skeletal muscle mass/ body mass) × 100.”
BackgroundMethodGoodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., Simonsick, E. M., Tylavsky, F. A., Visser, M., Newman, A. B., et al. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1059 · Cited by 3,083 · cited 3×
“Intramuscular and visceral fat increase with ageing while subcutaneous fat declines [18, 32, 33].”
BackgroundGuralnik, J. M., Ferrucci, L., Pieper, C. F., Leveille, S. G., Markides, K. S., Ostir, G. V., Studenski, S., Berkman, L. F., & Wallace, R. B. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.4.m221 · Cited by 2,898 · cited 2×
“suggested that timed usual gait provides a predictive value for the onset of disability [62].”
BackgroundMeaningful change and responsiveness in common physical performance measures in older adults.
Perera, S., Mody, S. H., Woodman, R. C., & Studenski, S. A. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00701.x · Cited by 2,513 · cited 1×
“Meaningful changes in the SPPB have been defined [59, 60].”
BackgroundEvans, W. J., Morley, J. E., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,450 · cited 2×
“Sarcopenia is one of the elements of the proposed definition for cachexia [22].”
BackgroundSarcopenia: origins and clinical relevance
Rosenberg, I. H. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.5.990s · Cited by 2,399 · cited 1×
“In 1989, Irwin Rosenberg proposed the term ‘sarcopenia’ (Greek ‘sarx’ or flesh + ‘penia’ or loss) to describe this age-related decrease of muscle mass [1, 2].”
Background
Research works printed but not linked: 1
- Abellan van Kan, 2009, Gait speed as a marker of adverse outcomes, 881
Cited by
Items 801–900 of 1,247
Arnold, W. D., & Clark, B. C. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101966 · Cited by 143
del Favero, S., Roschel, H., Solis, M. Y., Hayashi, A. P., Artioli, G. G., Otaduy, M. C., Benatti, F. B., Harris, R. C., Wise, J. A., Leite, C. C., et al. (2012) · Amino Acids · doi:10.1007/s00726-011-1190-x · Cited by 132
Interaction Between Bone and Muscle in Older Persons with Mobility Limitations
Ferrucci, L., Baroni, M., Ranchelli, A., Lauretani, F., Maggio, M., Mecocci, P., & Ruggiero, C. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660690 · Cited by 131
New Predictive Index for Lumbar Paraspinal Muscle Degeneration Associated With Aging
Takayama, K., Kita, T., Nakamura, H., Kanematsu, F., Yasunami, T., Sakanaka, H., & Yamano, Y. (2015) · Spine · doi:10.1097/brs.0000000000001154 · Cited by 140
“A wide range of measurement methods can be used to assess muscle mass, strength, and function.(7) Cost, availability, and ease of use can determine whether such methods are better suited for clinical practice or are more useful for research to define the natural course of sarcopenia.”
BackgroundSergi, G., Trevisan, C., Veronese, N., Lucato, P., & Manzato, E. (2016) · European Journal of Radiology · doi:10.1016/j.ejrad.2016.04.009 · Cited by 153
Diagnostic Criteria and Clinical Outcomes in Sarcopenia Research: A Literature Review
Han, A., Bokshan, S., Marcaccio, S., DePasse, J., & Daniels, A. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7040070 · Cited by 126
Sarcopenia in Chronic Liver Disease: Impact on Outcomes
Ooi, P. H., Hager, A., Mazurak, V. C., Dajani, K. Z., Bhargava, R., Gilmour, S. M., & Mager, D. R. (2019) · Liver Transplantation · doi:10.1002/lt.25591 · Cited by 139
Exercise-mediated reinnervation of skeletal muscle in elderly people: An update
Coletti, C., Acosta, G. F., Keslacy, S., & Coletti, D. (2022) · European Journal of Translational Myology · doi:10.4081/ejtm.2022.10416 · Cited by 136
Landi, F., Liperoti, R., Russo, A., Giovannini, S., Tosato, M., Barillaro, C., Capoluongo, E., Bernabei, R., & Onder, G. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0437-y · Cited by 146
Self-citationAssociation of sarcopenia with functional decline in community‐dwelling elderly subjects in Japan
Tanimoto, Y., Watanabe, M., Sun, W., Tanimoto, K., Shishikura, K., Sugiura, Y., Kusabiraki, T., & Kono, K. (2013) · Geriatrics & Gerontology International · doi:10.1111/ggi.12037 · Cited by 128
Ageing well: a review of sarcopenia and frailty
Keevil, V. L., & Romero‐Ortuño, R. (2015) · Proceedings of The Nutrition Society · doi:10.1017/s0029665115002037 · Cited by 149
Collagen Type III and VI Turnover in Response to Long-Term Immobilization
Sun, S., Henriksen, K., Karsdal, M. A., Byrjalsen, I., Rittweger, J., Armbrecht, G., Belavy, D. L., Felsenberg, D., & Nedergaard, A. F. (2015) · PLOS ONE · doi:10.1371/journal.pone.0144525 · Cited by 131
“We can also observe a loss of 8% LBM (from DXA) in the lower body in the CTRL group and 4% in the RVE group, however, there is no change or even a small increase in upper body LBM [30].”
BackgroundMethodInfluentialIshibashi, H. (2018) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2018.09.004 · Cited by 139
“Sarcopenia is defined as the condition of decreased muscle mass of extremities [6], accompanied with decreased grip power or gait speed [7,8].”
BackgroundMartin, L., Gioulbasanis, I., Senesse, P., & Baracos, V. E. (2020) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1597 · Cited by 128
Sarcopenia and health-related outcomes: an umbrella review of observational studies
the Special Interest Groups in Systematic Reviews and Meta-analyses for healthy ageing Sarcopenia and Frailty and resilience in older persons of the European Geriatric Medicine Society (EuGMS), Veronese, N., Demurtas, J., Soysal, P., Smith, L., Torbahn, G., Schoene, D., Schwingshackl, L., Sieber, C. C., Bauer, J. M., et al. (2019) · European Geriatric Medicine · doi:10.1007/s41999-019-00233-w · Cited by 140
Self-citationBeneficial Effects of Leucine Supplementation on Criteria for Sarcopenia: A Systematic Review
Martínez-Arnau, F. M., Fonfría-Vivas, R., & Cauli, O. (2019) · Nutrients · doi:10.3390/nu11102504 · Cited by 129
“Regarding methodological issues, our analysis highlighted that different sarcopenia evaluation methods have often failed to adequately meet the criteria proposed by the international guidelines [1,72,73].”
BackgroundInfluentialImpaired proteostasis during skeletal muscle aging
Fernando, R., Drescher, C., Nowotny, K., Grune, T., & Castro, J. P. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.08.037 · Cited by 134
Shin, M. J., Jeon, Y. K., & Kim, I. J. (2018) · The World Journal of Men's Health · doi:10.5534/wjmh.180001 · Cited by 134
Sheean, P. M., Peterson, S. J., Gomez Perez, S., Troy, K. L., Patel, A., Sclamberg, J. S., Ajanaku, F. C., & Braunschweig, C. A. (2014) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607113500308 · Cited by 130
Kim, M., & Kim, H. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.9 · Cited by 140
Strandberg, T. E., Pitkälä, K. H., & Tilvis, R. S. (2011) · European Geriatric Medicine · doi:10.1016/j.eurger.2011.08.003 · Cited by 167
“Comprehensive reviews have been recently published on anorexia/weight loss [91], sarcopenia/dynapenia [92–98], cachexia [98,99], and exhaustion/fatigue [100].”
BackgroundSuzuki, Y., Okamoto, T., Fujishita, T., Katsura, M., Akamine, T., Takamori, S., Morodomi, Y., Tagawa, T., Shoji, F., & Maehara, Y. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.08.007 · Cited by 134
Manoy, P., Yuktanandana, P., Tanavalee, A., Anomasiri, W., Ngarmukos, S., Tanpowpong, T., & Honsawek, S. (2017) · Nutrients · doi:10.3390/nu9080799 · Cited by 127
Kemmler, W., Weissenfels, A., Teschler, M., Willert, S., Bebenek, M., Shojaa, M., Kohl, M., Freiberger, E., Sieber, C., & von Stengel, S. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s137987 · Cited by 123
Handgrip Strength Cannot Be Assumed a Proxy for Overall Muscle Strength
Yeung, S. S. Y., Reijnierse, E. M., Trappenburg, M. C., Hogrel, J., McPhee, J. S., Piasecki, M., Sipilä, S., Salpakoski, A., Butler-Browne, G. S., Pääsuke, M., et al. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.04.019 · Cited by 143
Fukuoka, Y., Narita, T., Fujita, H., Morii, T., Sato, T., Sassa, M. H., & Yamada, Y. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.12908 · Cited by 129
Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review
Aleixo, G. F. P., Williams, G. R., Nyrop, K. A., Muss, H. B., & Shachar, S. S. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05352-3 · Cited by 137
Sarcopenia in chronic liver disease: mechanisms and countermeasures
Allen, S., Quinlan, J. I., Dhaliwal, A., Armstrong, M. J., Elsharkawy, A. M., Greig, C. A., Lord, J. M., Lavery, G. G., & Breen, L. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00373.2020 · Cited by 144
Bosy-Westphal, A., & Müller, M. J. (2015) · International Journal of Obesity · doi:10.1038/ijo.2014.161 · Cited by 133
Wang, H., Hai, S., Cao, L., Zhou, J., Liu, P., & Dong, B.-R. (2016) · BMC Geriatrics · doi:10.1186/s12877-016-0386-z · Cited by 124
Systematic Review and Meta-Analysis of the Association Between Sarcopenia and Dysphagia
Zhao, W., Yang, M. J., Wu, H.-M., Yang, L., Zhang, X., & Huang, Y. (2018) · The journal of nutrition health & aging · doi:10.1007/s12603-018-1055-z · Cited by 146
“In 2010, EWGSOP presented a practical clinical definition and diagnostic criteria for sarcopenia.”
InfluentialBachettini, N. P., Bielemann, R. M., Barbosa-Silva, T. G., Menezes, A. M. B., Tomasi, E., & González, M. C. (2019) · European Journal of Clinical Nutrition · doi:10.1038/s41430-019-0508-8 · Cited by 143
Double burden of malnutrition in persons with obesity
Barazzoni, R., & Gortan Cappellari, G. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09578-1 · Cited by 120
Zhang, X., Chen, D., Xie, X., Zhang, J., Zeng, Y., & Cheng, A. S. K. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02276-w · Cited by 141
Sarcopenic Obesity: An Emerging Public Health Problem
Ji, T., Li, Y., & Ma, L. (2022) · Aging and disease · doi:10.14336/ad.2021.1006 · Cited by 124
Mitchell, C. J., Milan, A. M., Mitchell, S. M., Zeng, N., Ramzan, F., Sharma, P., Knowles, S. O., Roy, N. C., Sjödin, A., Wagner, K.-H., et al. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.160325 · Cited by 132
Definitions of Sarcopenia: Associations with Previous Falls and Fracture in a Population Sample
Clynes, M. A., Edwards, M. H., Buehring, B., Dennison, E. M., Binkley, N., & Cooper, C. (2015) · Calcified Tissue International · doi:10.1007/s00223-015-0044-z · Cited by 126
Psutka, S. P., Boorjian, S. A., Moynagh, M. R., Schmit, G. D., Costello, B. A., Thompson, R. H., Stewart-Merrill, S. B., Lohse, C. M., Cheville, J. C., Leibovich, B. C., et al. (2016) · Journal of Urology · doi:10.1016/j.juro.2015.08.072 · Cited by 135
Recent advances in the biology and therapy of muscle wasting
Glass, D., & Roubenoff, R. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05809.x · Cited by 128
Yadav, A., Chang, Y., Carpenter, S., Silva, A. C., Rakela, J., Aqel, B. A., Byrne, T. J., Douglas, D. D., Vargas, H. E., & Carey, E. J. (2015) · Clinical Transplantation · doi:10.1111/ctr.12493 · Cited by 130
Liu, L.-K., Lee, W., Chen, L., Hwang, A., Lin, M.-H., Peng, L., & Chen, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136968 · Cited by 153
“[8] Moreover, frailty is closely associated with body compositional changes and osteoporosis,[9] and may overlap with the pathogenesis of sarcopenia.[10] Despite extensive reports regarding frailty and related adverse health outcomes, the association of frailty and the changes of body composition has not been well und…”
BackgroundMcPhee, J. S., Cameron, J., Maden-Wilkinson, T., Piasecki, M., Yap, M. H., Jones, D. A., & Degens, H. (2018) · The Journals of Gerontology: Series A · doi:10.1093/gerona/gly040 · Cited by 119
Chang, K.-V., Wu, W.-T., Huang, K.-C., Jan, W. H., & Han, D.-S. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.03.019 · Cited by 130
“Dynapenia was defined as loss of handgrip strength with a cut-off value set at 30 kg for men and 20 kg for women (Cruz-Jentoft et al., 2010).”
The relationship between sarcopenia and fragility fracture—a systematic review
Wong, R. M. Y., Wong, H., Zhang, N., Chow, S. K., Chau, W., Wang, J., Chim, Y. N., Leung, K., & Cheung, W. (2019) · Osteoporosis International · doi:10.1007/s00198-018-04828-0 · Cited by 142
“In 2010, the EuropeanWorkingGroup on Sarcopenia in Older People (EWGSOP) developed a clinical definition of sarcopenia [2].”
BackgroundMethodInfluentialSarcopenia and frailty in individuals with dementia: A systematic review
Waite, S. J., Maitland, S., Thomas, A. J., & Yarnall, A. J. (2020) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2020.104268 · Cited by 139
Lifestyle and Sarcopenia – Etiology, Prevention and Treatment
Rom, O., Kaisari, S., Aizenbud, D., & Reznick, A. Z. (2012) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10091 · Cited by 130
Malafarina, V., Uriz-Otano, F., Malafarina, C., Martinez, J. A., & Zulet, M. A. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.04.010 · Cited by 131
Motoneuron Loss Is Associated With Sarcopenia
Drey, M., Krieger, B., Sieber, C. C., Bauer, J. M., Hettwer, S., Bertsch, T., Dahinden, P., Mäder, A., Vrijbloed, J. W., Schuster, G. M., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.02.002 · Cited by 141
Self-citationSandini, M., Bernasconi, D. P., Fior, D., Molinelli, M., Ippolito, D., Nespoli, L. C., Caccialanza, R., & Gianotti, L. V. (2016) · Nutrition · doi:10.1016/j.nut.2016.04.002 · Cited by 139
Kaplan, S. J., Pham, T. N., Arbabi, S., Gross, J. A., Damodarasamy, M., Bentov, I., Taitsman, L. A., Mitchell, S. H., & Reed, M. J. (2016) · JAMA Surgery · doi:10.1001/jamasurg.2016.4604 · Cited by 136
Mayr, R., Gierth, M., Zeman, F., Reiffen, M., Seeger, P., Wezel, F., Pycha, A., Comploj, E., Bonatti, M., Ritter, M., et al. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12279 · Cited by 136
Verschuren, O. W., Smorenburg, A. R. P., Luiking, Y. C., Bell, K. L., Barber, L. A., & Peterson, M. D. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12287 · Cited by 140
Deng, H., Zha, P., Peng, L., Hou, L., Huang, K., & Li, X. (2018) · Diseases of the Esophagus · doi:10.1093/dote/doy115 · Cited by 136
The effect of malnutrition on mortality in hospitalized patients with hematologic malignancy
Yılmaz, M., Köseoğlu, F. D., Şahin, F., & Saydam, G. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04952-5 · Cited by 146
Therakomen, V., Petchlorlian, A., & Lakananurak, N. (2020) · Scientific Reports · doi:10.1038/s41598-020-75250-y · Cited by 149
Paintin, J., Cooper, C. C., & Dennison, E. M. (2018) · British Journal of Hospital Medicine · doi:10.12968/hmed.2018.79.5.253 · Cited by 143
Osteosarcopenia: A Narrative Review on Clinical Studies
Polito, A., Barnaba, L., Ciarapica, D., & Azzini, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105591 · Cited by 136
“Sarcopenia is a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength associated with the risk of adverse outcomes such as physical disability, poor quality of life, and death [5].”
BackgroundLozano-Montoya, I., Correa-Pérez, A., Abraha, I., Soiza, R. L., Cherubini, A., O'Mahony, D., & Cruz-Jentoft, A. J. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s132496 · Cited by 130
Self-citationSharma, P., Zargar‐Shoshtari, K., Caracciolo, J. T., Fishman, M., Poch, M. A., Pow‐Sang, J. M., Sexton, W. J., & Spiess, P. E. (2015) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2015.01.011 · Cited by 136
“gold standard definitions [20].”
Nishiguchi, S., Yamada, M., Fukutani, N., Adachi, D., Tashiro, Y., Hotta, T., Morino, S., Shirooka, H., Nozaki, Y., Hirata, H., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.07.010 · Cited by 136
Lodewick, T. M., van Nijnatten, T. J. A., van Dam, R. M., van Mierlo, K., Dello, S. A. W. G., Neumann, U. P., Olde Damink, S. W. M., & Dejong, C. H. C. (2015) · HPB · doi:10.1111/hpb.12373 · Cited by 129
“Moreover, we based sarcopenia on CT-based measurements, the gold standard for estimating muscle mass.(37) The main drawbacks, however, of the present study are the retrospective design and the calculation of percentage body fat.”
MethodRegenerative function of immune system: Modulation of muscle stem cells
Saini, J., McPhee, J. S., Al-Dabbagh, S., Stewart, C. E., & Al‐Shanti, N. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.03.006 · Cited by 145
“…atrophies considerably (Maden-Wilkinson et al., 2014; Lexell et al., 105 1988; Janssen et al., 2002; Lexell, 1995; Morley et al., 2001), which contributes to weakness and 106 mobility impairments inherent to sarcopenia (Janssen, 2011; Cruz-Jentoft et al., 2010) and frailty 107 (Fried et al., 2001).”
BackgroundDiet, exercise, and pharmacotherapy for sarcopenia in people with diabetes
Hashimoto, Y., Takahashi, F., Okamura, T., Hamaguchi, M., & Fukui, M. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155585 · Cited by 132
Muscle wasting and aging: Experimental models, fatty infiltrations, and prevention
Brioche, T., Pagano, A. F., Py, G., & Chopard, A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.04.006 · Cited by 129
“Characteristics of sarcopenia-related muscle deconditioning The three components of sarcopenia are low muscle mass, low muscle strength, and poor physical performance (Cruz-Jentoft et al., 2010; Fielding et al., 2011; Morley et al., 2011; Muscaritoli et al., 2010).”
BackgroundMethodInfluentialOtsuji, H., Yokoyama, Y., Ebata, T., Igami, T., Sugawara, G., Mizuno, T., & Nagino, M. (2015) · World Journal of Surgery · doi:10.1007/s00268-015-2988-6 · Cited by 140
Identifying Sarcopenia in Acute Care Setting Patients
Rossi, A. P., Fantin, F., Micciolo, R., Bertocchi, M., Bertassello, P., Zanandrea, V., Zivelonghi, A., Bissoli, L., & Zamboni, M. M. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.018 · Cited by 152
Self-citationSarcopenia and Fragility Fractures: Molecular and Clinical Evidence of the Bone-Muscle Interaction
Tarantino, U., Piccirilli, E., Fantini, M., Baldi, J., Gasbarra, E., & Bei, R. (2015) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.n.00648 · Cited by 129
Sarcopenia in COPD: relationship with COPD severity and prognosis
Costa, T. M. D. R. L., Costa, F. M., Moreira, C. A., Rabelo, L. M., Boguszewski, C. L., & Borba, V. Z. C. (2015) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132015000000040 · Cited by 141
“To make the densitometric diagnosis of sarcopenia, we applied the Baumgartner criteria for individuals with a BMI < 22 kg/m2 and the Newman criteria for individuals with a BMI ≥ 22 kg/m2.(21)”
MethodCachexia in cancer: what is in the definition?
Vanhoutte, G., van de Wiel, M., Wouters, K., Sels, M., Bartolomeeussen, L., Keersmaecker, S. D., Verschueren, C., Vroey, V. D., Wilde, A. D., Smits, E., et al. (2016) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2016-000097 · Cited by 143
Handgrip Strength in Old and Very Old Adults: Mood, Cognition, Function, and Mortality
Stessman, J., Rottenberg, Y., Fischer, M., Hammerman‐Rozenberg, A., & Jacobs, J. M. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14509 · Cited by 140
Cawthon, P. M., Lui, L.-Y., Taylor, B. C., McCulloch, C. E., Cauley, J. A., Lapidus, J., Orwoll, E., & Ensrud, K. E. (2017) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glw327 · Cited by 124
Influence of Aging and Environment on Presentation of Infection in Older Adults
Chakhtoura, N. G. E., Bonomo, R. A., & Jump, R. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.07.017 · Cited by 136
Chronic inflammation and sarcopenia: A regenerative cell therapy perspective
Chhetri, J. K., Barreto, P. D. S., Fougère, B., Rolland, Y., Vellas, B. J., & Cesari, M. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2017.12.023 · Cited by 135
“Sarcopenia is a very common condition in older adults (Cruz-Jentoft et al., 2014), and is associated with a myriad of adverse events including disability, hospitalization, and mortality (Cruz-Jentoft et al., 2010).”
BackgroundSelf-citationFalls among older adults in the South of Brazil: prevalence and determinants
Vieira, L. S., Gomes, A. P., Bierhals, I. O., Farías-Antúnez, S., Ribeiro, C. G., Miranda, V. I. A., Lutz, B. H., Barbosa-Silva, T. G., Lima, N. P., Bertoldi, A. D., et al. (2018) · Revista de Saúde Pública · doi:10.11606/s1518-8787.2018052000103 · Cited by 148
The impact of sarcopenic obesity on knee and hip osteoarthritis: a scoping review
Godziuk, K., Prado, C. M. M., Woodhouse, L. J., & Forhan, M. A. (2018) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-018-2175-7 · Cited by 132
“Of the studies in this scoping review, seven used only body composition/low muscle mass for sarcopenia identification [60, 61, 63, 64, 67–69], three used only an assessment of muscle weakness (testing handgrip [66] or quadriceps strength [59, 62]), and only one study utilized a combined approach following EWGSOP conse…”
BackgroundPrevalence of rheumatoid cachexia in rheumatoid arthritis: a systematic review and meta‐analysis
Santo, R. C. D. E., Fernandes, K., Lora, P. S., Filippin, L. I., & Xavier, R. M. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12320 · Cited by 137
Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer
Lee, J. S., Kim, Y. S., Kim, E. Y., & Jin, W. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202700 · Cited by 136
The analysis of osteosarcopenia as a risk factor for fractures, mortality, and falls
Teng, Z., Zhu, Y., Teng, Y., Long, Q., Hao, Q., Yu, X., Yang, L., Lv, Y., Liu, J., Zeng, Y., et al. (2021) · Osteoporosis International · doi:10.1007/s00198-021-05963-x · Cited by 134
“Secondly, we found that osteosarcopenia significantly increased the risk of mortality in each subgroup as follows: American subgroup, OR 1.97, 95% CI 1.21–3.22; Australian subgroup, OR 1.49, 95% CI 1.01–2.20; non-osteosarcopenia subgroup, OR 1.80, 95% CI 1.09–2.98; healthy subgroup, OR 1.59, 95% CI 1.08–2.33; osteopen…”
BackgroundMethodInfluentialRespiratory sarcopenia: A position paper by four professional organizations
Sato, S., Miyazaki, S., Tamaki, A., Yoshimura, Y., Arai, H., Fujiwara, D., Katsura, H., Kawagoshi, A., Kozu, R., Maeda, K., et al. (2022) · Geriatrics & Gerontology International · doi:10.1111/ggi.14519 · Cited by 112
Shimokata, H., Ando, F., Yuki, A., & Otsuka, R. (2014) · Geriatrics & Gerontology International · doi:10.1111/ggi.12219 · Cited by 123
Spurious Inferences about Long-Term Outcomes: The Case of Severe Sepsis and Geriatric Conditions
Iwashyna, T. J., Netzer, G., Langa, K. M., & Cigolle, C. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201109-1660oc · Cited by 130
Park, S. K., Richardson, C. R., Holleman, R. G., & Larson, J. L. (2013) · Heart & Lung · doi:10.1016/j.hrtlng.2012.07.004 · Cited by 140
Hamaguchi, Y., Kaido, T., Okumura, S., Ito, T., Fujimoto, Y., Ogawa, K., Mori, A., Hammad, A., Hatano, E., & Üemoto, S. (2015) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.236 · Cited by 133
“Sarcopenia is defined as a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength [1].”
BackgroundFrailty, Sarcopenia, and Hormones
Morley, J. E., & Malmstrom, T. K. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.02.006 · Cited by 143
Umegaki, H. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12365 · Cited by 139
Sarcopenia and the cardiometabolic syndrome: A narrative review
Bahat, G., & İlhan, B. (2016) · European Geriatric Medicine · doi:10.1016/j.eurger.2015.12.012 · Cited by 144
KEMMLER, W. K., Teschler, M., Weißenfels, A., Bebenek, M., von Stengel, S., Kohl, M., Freiberger, E., Goisser, S., Jakob, F. J., Sieber, C. C., et al. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3662-z · Cited by 142
Functional Capacity and Levels of Physical Activity in Aging: A 3-Year Follow-up
Tomás, M. T., Galán-Mercant, A., Carnero, E. Á., & Fernandes, B. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2017.00244 · Cited by 147
Sarcopenic obesity in cirrhosis—The confluence of 2 prognostic titans
Eslamparast, T., Montano‐Loza, A. J., Raman, M., & Tandon, P. (2018) · Liver International · doi:10.1111/liv.13876 · Cited by 123
Zhang, X., Wang, C., Dou, Q., Zhang, W., Yang, Y., & Xie, X. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-021252 · Cited by 127
“Exclusion criteria were as follows: (1) type of participant: community-dwelling older people (aged 65 years or older) or hospitalised older people; (2) article type: only abstract, letters and laboratory research; review articles; (3) insufficient data; (4) other languages of studies, except English; (5) no clear defi…”
BackgroundMethodCawthon, P. M., Travison, T. G., Manini, T. M., Patel, S., Pencina, K. M., Fielding, R. A., Magaziner, J. M., Newman, A. B., Brown, T., Kiel, D. P., et al. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz081 · Cited by 127
Self-citationFrailty phenotype and chronic kidney disease: a review of the literature
Musso, C. G., Jáuregui, J. R., & Núñez, J. F. M. (2015) · International Urology and Nephrology · doi:10.1007/s11255-015-1112-z · Cited by 127
Shin, H. I., Kim, D., Seo, K. M., Kang, S. H., Lee, S. Y., & Son, S. (2017) · Annals of Rehabilitation Medicine · doi:10.5535/arm.2017.41.4.686 · Cited by 139
Bhuachalla, Ē. N., Daly, L. E., Power, D. G., Cushen, S. J., MacEneaney, P. M., & Ryan, A. M. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12258 · Cited by 134
Validity of the Mini-Nutritional Assessment Scale for Evaluating Frailty Status in Older Adults
Soysal, P., Işık, A. T., Arık, F., Kalan, U., Eyvaz, A., & Veronese, N. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.07.016 · Cited by 130
Sarcopenia and fatty liver disease
Kim, J. A., & Choi, K. M. (2019) · Hepatology International · doi:10.1007/s12072-019-09996-7 · Cited by 134
Nakanishi, N., Tsutsumi, R., Okayama, Y., Takashima, T., Ueno, Y., Itagaki, T., Tsutsumi, Y. M., Sakaue, H., & Oto, J. (2019) · Journal of Intensive Care · doi:10.1186/s40560-019-0416-y · Cited by 130
Application of mesenchymal stem cell therapy for aging frailty: from mechanisms to therapeutics
Zhu, Y., Ge, J., Huang, C., Liu, H., & Jiang, H. (2021) · Theranostics · doi:10.7150/thno.46436 · Cited by 132
Wang, Y.-J., Wang, Y., Zhan, J.-K., Tang, Z.-Y., He, J.-Y., Tan, P., Deng, H.-Q., Huang, W., & Liu, Y.-S. (2015) · International Journal of Endocrinology · doi:10.1155/2015/482940 · Cited by 126
“Sarcopenia, the age-related loss of skeletal muscle mass, is characterized by the deterioration of muscle quantity and quality leading to a gradual slowing of movement, a decline in strength and power, increased risk of fall-related injury, and often, frailty [4].”
BackgroundKim, J.-H., Cho, J. J., & Park, Y. S. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.3.264 · Cited by 126
Metadata
- Authors
- Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., Topinková, E., Vandewoude, M., & Zamboni, M.
- Affiliations
- Hospital Universitario Ramón y Cajal (ES)
- Damiaan Dicht bij het leven (BE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Clermont Université 4 , UFR Médecine, UMR 1019, F-63001 Clermont-Ferrand , France
- Uppsala University (SE)
- Università Cattolica del Sacro Cuore (IT)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- University Hospital of Geneva (CH)
- Hôpital de La Grave (FR)
- Centre Hospitalier Universitaire de Nice (FR)
- Charles University (CZ)
- University of Antwerp (BE)
- University of Verona (IT)
- Corresponding author
- Cruz-Jentoft, Alfonso J.
- ORCID
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-04-13
- Volume
- 39
- Issue
- 4
- Pages
- 412-423
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- PMC
- PMC2886201
- OpenAlex
- W2102902846
- Cited by
- 11,601
- References
- 80
- Citations by year
- 2026: 468 · 2025: 791 · 2024: 879 · 2023: 913 · 2022: 1031 · 2021: 1056 · 2020: 1131 · 2019: 1021 · 2018: 1059 · 2017: 811 · 2016: 685 · 2015: 591 · 2014: 494 · 2013: 290 · 2012: 207
- FWCI
- 142.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Age and Ageing (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- reroDoc Digital Library (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- European Geriatric Medicine Society
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- sarcopenia, older adults, diagnostic criteria, muscle mass, muscle strength, physical performance, walking speed, grip strength, sarcopenic obesity, frailty, cachexia, pre-sarcopenia, cut-off values, case-finding algorithms, comprehensive geriatric assessment
- MeSH terms
- Aged, Aged, 80 and over, Aging, Cachexia, Female, Humans, Male, Obesity, Geriatric Assessment, Frail Elderly, Muscle, Skeletal, Muscle Strength, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

